InHEART, a pioneering company in the field of medical devices, has recently obtained FDA 510(k) clearance for its innovative AI software module. This module introduces a groundbreaking feature: fully automated segmentation of CT images, which is a first-of-its-kind advancement in creating 3D cardiac models. With this breakthrough technology, InHEART can now provide its solution to physicians more rapidly and efficiently than ever before.
The main objective of the InHEART solution is to revolutionize traditional ablation procedures by generating highly detailed 3D models of the heart. These models are created using proprietary segmentation algorithms that analyze pre-procedural CT and/or MR images.
This detailed information empowers physicians to customize treatment strategies based on the unique cardiac anatomy of each patient. Additionally, it facilitates pre-procedural planning and seamless integration into all major electroanatomic mapping (EAM) systems. With the introduction of this AI-driven module, InHEART significantly enhances its ability to efficiently provide its solution to physicians. This represents a notable advancement in the field of cardiac care.
Source: https://www.prnewswire.com/news-releases/inheart-receives-fda-clearance-for-advanced-ai-driven-software-module-that-optimizes-the-creation-of-3d-models-of-the-heart-302092843.html
